LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
33 hedge funds and large institutions have $124M invested in LogicBio Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Holders
33
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$837K | |
| 2 | +$537K | |
| 3 | +$227K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$82.3K |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
+$57K |
Top Sellers
| 1 | -$675K | |
| 2 | -$578K | |
| 3 | -$543K | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$156K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$146K |